Ethicon Physiomesh Flexible Composite Hernia Mesh

The Ethicon Physiomesh docket shows zero actions currently pending in the coordinated proceeding, according to the JPML's most recent report, even though the underlying litigation, over a laparoscopic hernia mesh product that Ethicon voluntarily withdrew from the market in 2016 after data suggested higher recurrence and reoperation rates than comparable products, historically involved a substantial claim population. For a funder, that zero-pending status is the key structural fact: it indicates the MDL-stage inventory here has fully wound down.

As with any docket showing a zero-pending status, that does not necessarily mean every underlying Physiomesh-related claim has been resolved system-wide; it means there is no active coordinated federal inventory to originate new funding against today. A firm or funder encountering a claim connected to this product would need to determine independently where that claim currently sits, since it would not be found active within this MDL.

Given the absence of any remaining MDL-stage inventory, this docket does not currently support new single-matter or portfolio financing activity. If new Physiomesh-related actions were filed and transferred into this MDL in the future, that would represent a meaningful change to the docket's status and would warrant fresh diligence at that time.

A structural read on how and when this docket's inventory resolved is available through Criterica Intelligence for firms seeking to understand the litigation's history before evaluating any claim connected to this product found elsewhere in the legal system.

Pre-settlement funding is a non-recourse purchase of a portion of the proceeds of a pending legal claim — not a loan. If the case does not result in a recovery, nothing is owed. Rates, fees, and repayment terms are disclosed in full in the funding agreement, which the applicant’s attorney reviews before signing. Availability and terms vary by state.